Siyuan Zhang

ResearcherID ORCID

Publication Activity (10 Years)

Years Active: 2019-2024
Publications (10 Years): 12

Top Topics

Extracellular Matrix

Positive Breast Cancer

Top Venues

Nature communications

Research square

Cancer research

Scientific reports

This page only lists publications with an associated author ORCID identifier.

Publications

James Zhu, Yunguan Wang, Woo Yong Chang, Alicia Malewska, Fabiana Napolitano, Jeffrey C Gahan, Nisha Unni, Min Zhao, Rongqing Yuan, Fangjiang Wu, Lauren Yue, Lei Guo, Zhuo Zhao, Danny Z Chen, Raquibul Hannan, Siyuan Zhang, Guanghua Xiao, Ping Mu, Ariella B Hanker, Douglas Strand, Carlos L Arteaga, Neil Desai, Xinlei Wang, Yang Xie, Tao Wang
Mapping cellular interactions from spatially resolved transcriptomics data. Nature methods (2024)
Shidan Wang, Ruichen Rong, Qin Zhou, Donghan M Yang, Xinyi Zhang, Xiaowei Zhan, Justin Bishop, Zhikai Chi, Clare J Wilhelm, Siyuan Zhang, Curtis R Pickering, Mark G Kris, John D Minna, Yang Xie, Guanghua Xiao
Deep learning of cell spatial organizations identifies clinically relevant insights in tissue images. Nature communications 14 (1) (2023)
Guanghua Xiao, Shidan Wang, Ruichen Rong, Donghan Yang, Xinyi Zhang, Xiaowei Zhan, Justin Bishop, Clare Wilhelm, Siyuan Zhang, Curtis Pickering, Mark Kris, John D Minna, Yang Xie
Deep Learning of Cell Spatial Organizations Identifies Clinically Relevant Insights in Tissue Images. Research square (2023)
Bhavana Palakurthi, Shaneann R Fross, Ian H Guldner, Emilija Aleksandrovic, Xiyu Liu, Anna K Martino, Qingfei Wang, Ryan A Neff, Samantha M Golomb, Cheryl M Lewis, Yan Peng, Erin N Howe, Siyuan Zhang
Targeting CXCL16 and STAT1 augments immune checkpoint blockade therapy in triple-negative breast cancer. Nature communications 14 (1) (2023)
Loan Bui, Shanique Edwards, Eva Hall, Laura Alderfer, Kellen J Round, Madeline Owen, Pietro Sainaghi, Siyuan Zhang, Prakash D Nallathamby, Laura S Haneline, Donny Hanjaya-Putra
Engineering bioactive nanoparticles to rejuvenate vascular progenitor cells. Communications biology 5 (1) (2022)
Sangnam Kim, Siyuan Zhang, Sangpil Yoon
Multiplexed Ultrasound Imaging Using Spectral Analysis on Gas Vesicles. Advanced healthcare materials 11 (17) (2022)
Gokhan Bahcecioglu, Xiaoshan Yue, Erin N Howe, Ian H Guldner, M Sharon Stack, Harikrishna Nakshatri, Siyuan Zhang, Pinar Zorlutuna
Aged Breast Extracellular Matrix Drives Mammary Epithelial Cells to an Invasive and Cancer-Like Phenotype. Advanced science (Weinheim, Baden-Wurttemberg, Germany) 8 (22) (2021)
Erin N Howe, Miranda D Burnette, Melanie E Justice, Patricia M Schnepp, Victoria Hedrick, James W Clancy, Ian H Guldner, Alicia T Lamere, Jun Li, Uma K Aryal, Crislyn D'Souza-Schorey, Jeremiah J Zartman, Siyuan Zhang
Rab11b-mediated integrin recycling promotes brain metastatic adaptation and outgrowth. Nature communications 11 (1) (2020)
Marwa Asem, Allison M Young, Carlysa Oyama, Alejandro Claure De La Zerda, Yueying Liu, Jing Yang, Tyvette S Hilliard, Jeffery Johnson, Elizabeth I Harper, Ian Guldner, Siyuan Zhang, Toni Page-Mayberry, William J Kaliney, M Sharon Stack
Host Wnt5a Potentiates Microenvironmental Regulation of Ovarian Cancer Metastasis. Cancer research 80 (5) (2020)
Clay Conner, Tyson W Lager, Ian H Guldner, Min-Zu Wu, Yuriko Hishida, Tomoaki Hishida, Sergio Ruiz, Amanda E Yamasaki, Robert C Gilson, Juan Carlos Izpisua Belmonte, Peter C Gray, Jonathan A Kelber, Siyuan Zhang, Athanasia D Panopoulos
Cell surface GRP78 promotes stemness in normal and neoplastic cells. Scientific reports 10 (1) (2020)
Yingjia Ni, Keon R Schmidt, Barnes A Werner, Jenna K Koenig, Ian H Guldner, Patricia M Schnepp, Xuejuan Tan, Lan Jiang, Misha Host, Longhua Sun, Erin N Howe, Junmin Wu, Laurie E Littlepage, Harikrishna Nakshatri, Siyuan Zhang
Death effector domain-containing protein induces vulnerability to cell cycle inhibition in triple-negative breast cancer. Nature communications 10 (1) (2019)
Qingfei Wang, Ian H Guldner, Samantha M Golomb, Longhua Sun, Jack A Harris, Xin Lu, Siyuan Zhang
Single-cell profiling guided combinatorial immunotherapy for fast-evolving CDK4/6 inhibitor-resistant HER2-positive breast cancer. Nature communications 10 (1) (2019)